Bioequivalence study of postcoital emergency contraceptions containing levonorgestrel

Journal of the Medical Association of Thailand

Volumn 87, Issue SUPPL. 2, 2004, Pages

  Chompootaweep, Sumana ^a   Leepipatpibul, Samai ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Bioequivalence; Emergency contraception; Levonorgestrel; Postcoital contraception

Indexed keywords

LEVONORGESTREL; NORGESTREL;

ADULT; ARTICLE; BIOEQUIVALENCE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; EMERGENCY CONTRACEPTION; FEMALE; HUMAN; MENSTRUAL CYCLE; PREGNANCY; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; TABLET;

ADULT; CONTRACEPTIVES, POSTCOITAL, SYNTHETIC; FEMALE; HUMANS; LEVONORGESTREL; NORGESTREL; THERAPEUTIC EQUIVALENCY;

EID: 22744441463     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Task Force on Postovulatory Methods of Fertility Regulation. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 1998; 352: 428-33.
2. Trussell J. Emergency contraception: WHO Task Force study. Lancet 1998; 352: 1222-23.
3. Kubba AA, White JO, Guilleband J, et al. The biochemistry of human endometrium after two regimens of postcoital contraception: A dl-norgestrel/ethiny-lestradiol combination or danazol. Fertil Steril 1986; 45: 512-6.
4. Van Look PFA, Postcoital contraception: a cover-up story. In: Diczfalusy E and Bygdeman M, eds. Fertility Regulation Today and Tomorrow. New York: Raven Press, 1987: pp29-42.
5. WHO Task Force on Postovulatory Methods of Fertility Regulation. Postcoital contraception with levonorgestrel during the periovulatory phase of the menstrual cycle. Contraception 1987; 36: 275-86.
6. Ho PC, Kwan MSW. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in postcoital contraception. Hum Reprod 1993; 8: 389-92.
7. Ellertson C, Blanchard K, Webb A, Bigrigg A, Haskell S. Emergency contraception. Lancet. 1998; 352: 1477.
8. Seregely G. Results of a multicentre trial of Postinor. Ther Hung 1982; 30: 72-8.
9. Rinehart W. Postcoital contraception - an appraisal. In: Series J. Population Reports. Washington. George Washington University Medical Center 1976: 141.
10. He CH, Shi YE, Xu JQ, Van Look PF. A multicenter clinical study on two types of levonorgestrel tablets administered for postcoital contraception. Int J Gynaecol Obstet 1991; 36: 43-8.
11. Shi YE, Zheng SH, Zhu YH, He CH, Yu PP, Fotherby K. Pharmacokinetic study of levonorgestrel used as a postcoital agent. Contraception. 1988; 37: 359-69.
12. He CH, Shi YE, Liao DL, Zhu YH, Xu JQ, Matlin SA, Fotherby K, Van Look PF. Comparative crossover pharmacokinetic study two types of postcoital contraceptive tablets containing levonorgestrel. Contraception 1990; 41: 557-67.
13. von Hertzen H, Piaggio G, Van Look PF. Emergency contraception with levonorgestrel or the Yuzpe regimen. Lancet 1998; 352: 1939.
14. Ahsan R, Sufi SB, Cekan S. Laboratory method manual for the RIA of levonorgestrel, norethisterone, medroxy-progesterone acetate. WHO Collaborating Center for Research in Human Reproduction (WHO CCR) and reference service in the immunoassay of hormone in human reproduction. 1988: 19-32.
15. Guidance statistical procedure for bioequivalence studies using a standard two-treatment crossover design. Division of Bioequivalence, Office of Generic Drugs. CDER USFDA, 1992: 1-12.
16. nd ed. New York: Marcel Dekker, 1994: 193-206.
17. Digne SV, Adams WP. Bioequivalence: A United States Regulatory Perspective. In: Welling PG, Tse FLS, Dighe SV, eds. Pharmaceutical Equivalence. New York: Marcel Dekker, 1991: 367-80.
18. nd ed. New York: Marcel Dekker, 1994: 237.
19. nd ed. New York: Marcel Dekker, 1995: 479-502.